Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma

Journal of Hepatology

Volumn 59, Issue 2, 2013, Pages 300-307

  Cucchetti, Alessandro ^a   Piscaglia, Fabio ^a   Cescon, Matteo ^a   Colecchia, Antonio ^a   Ercolani, Giorgio ^a   Bolondi, Luigi ^a   Pinna, Antonio D ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cirrhosis; Cost effectiveness; Hepatic resection; Hepatocellular carcinoma; Meta analysis; Radiofrequency ablation

Indexed keywords

ARTICLE; CHILD PUGH SCORE; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; EARLY CANCER; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; LIFE EXPECTANCY; LIVER CELL CARCINOMA; LIVER RESECTION; META ANALYSIS; MONTE CARLO METHOD; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RADIOFREQUENCY ABLATION; SENSITIVITY ANALYSIS; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUMOR VOLUME;

CE; CIRRHOSIS; COST-EFFECTIVENESS; HCC; HEPATIC RESECTION; HEPATOCELLULAR CARCINOMA; HR; META-ANALYSIS; NATIONAL HEALTHCARE SYSTEM; NHS; QALY; QUALITY-ADJUSTED LIFE-YEAR; RADIOFREQUENCY ABLATION; RELATIVE RISK; RFA; RR; WILLINGNESS-TO-PAY; WTP;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COST-BENEFIT ANALYSIS; HEPATECTOMY; HUMANS; LIFE EXPECTANCY; LIVER NEOPLASMS; MARKOV CHAINS; MONTE CARLO METHOD; QUALITY-ADJUSTED LIFE YEARS; RADIO WAVES;

EID: 84880254496     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.04.009     Document Type: Article

References (44)

1. V. Santi, D. Buccione, A. Di Micoli, G. Fatti, M. Frigerio, and F. Farinati The changing scenario of hepatocellular carcinoma over the last two decades in Italy J Hepatol 56 2012 397 405
2. K. Feng, J. Yan, X. Li, F. Xia, K. Ma, and S. Wang A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma J Hepatol 57 4 2012 794 802
3. J. Huang, L. Yan, Z. Cheng, H. Wu, L. Du, and J. Wang A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria Ann Surg 252 2010 903 912
4. M.S. Chen, J.Q. Li, Y. Zheng, R.P. Guo, H.H. Liang, and Y.Q. Zhang A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma Ann Surg 243 2006 321 328
5. P.E. Majno, G. Mentha, and V. Mazzaferro Partial hepatectomy versus radiofrequency ablation for hepatocellular carcinoma: confirming the trial that will never be, and some comments on the indications for liver resection Hepatology 51 2010 1116 1118
6. J. Bruix, M. Sherman, and American Association for the Study of Liver Diseases Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
7. European Association for The Study of The Liver, and European Organization for Research and Treatment of Cancer EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 2012 908 943
8. C.R. de Lope, S. Tremosini, A. Forner, M. Reig, and J. Bruix Management of HCC J Hepatol 56 2012 S75 S87
9. T. Livraghi, F. Meloni, M. Di Stasi, E. Rolle, L. Solbiati, and C. Tinelli Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 47 2008 82 89
10. A. Cucchetti, G. Ercolani, M. Vivarelli, M. Cescon, M. Ravaioli, and G. Ramacciato Is portal hypertension a contraindication to hepatic resection? Ann Surg 250 2009 922 928
11. A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gøtzsche, and J.P. Ioannidis The PRISMA statement for reporting systematic reviews and meta-analyzes of studies that evaluate health care interventions: explanation and elaboration PLoS Med 6 2009 e1000100 10.1371/journal. pmed.1000100
12. D.F. Stroup, J.A. Berlin, S.C. Morton, I. Olkin, G.D. Williamson, and D. Rennie Meta-analysis of observational studies in epidemiology - a proposal for reporting JAMA 283 2000 2008 2012
13. S.P. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med Res Methodol 20 2005 5 13
14. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
15. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
16. D.J. McLernon, J. Dillon, and P.T. Donnan Health-state utilities in liver disease: a systematic review Med Decis Making 28 2008 582 592
17. R.F. Velázquez, M. Rodríguez, C.A. Navascués, A. Linares, R. Pérez, and N.G. Sotorríos Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis Hepatology 37 2003 520 527
18. Italian Ministry of Health. Health planning and quality laws and documents-Fees in euros of specialistic service, prostheses and DRG. Available at: < http://www.ministerosalute.it/programmazione/normativa/sezNormativa >. Accessed March 2012.
19. M. Ruggeri, A. Cicchetti, and A. Gasbarrini The cost-effectiveness of alternative strategies against HBV in Italy Health Policy 102 2011 72 80
20. J. Bonastre, T. De Baère, D. Elias, S. Evrard, P. Rouanet, and C. Bazin Cost of radiofrequency ablation in the treatment of hepatic malignancies Gastroenterol Clin Biol 31 2007 828 835
21. J.E. Siegel, M.C. Weinstein, L.B. Russell, and M.R. Gold Recommendations for reporting cost-effectiveness analyzes. Panel on cost-effectiveness in health and medicine JAMA 276 1996 1339 1341
22. E. Fenwick, B.J. O'Brien, and A. Briggs Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions Health Econ 13 2004 405 415
23. G. D'Amico, G. Garcia-Tsao, and L. Pagliaro Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies J Hepatol 44 2006 217 231
24. Italian population life tables. Available at: < http://demo.istat.it/ >. Accessed May 2012.
25. B. Burnand, W.N. Kernan, and A.R. Feinstein Indexes and boundaries for "quantitative significance" in statistical decisions J Clin Epidemiol 43 1990 1273 1284
26. Z.W. Peng, X.J. Lin, Y.J. Zhang, H.H. Liang, R.P. Guo, and M. Shi Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study Radiology 262 2012 1022 1033
27. J.H. Wang, C.C. Wang, C.H. Hung, C.L. Chen, and S.N. Lu Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma J Hepatol 56 2012 412 418
28. C.M. Cho, W.Y. Tak, Y.O. Kweon, S.K. Kim, Y.H. Choi, and Y.J. Hwang The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma Korean J Hepatol 11 2005 59 71
29. H. Nishikawa, T. Inuzuka, H. Takeda, J. Nakajima, F. Matsuda, and A. Sakamoto Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma BMC Gastroenterol 11 2011 143
30. T. Takayama, M. Makuuchi, and K. Hasegawa Single HCC smaller than 2 cm: surgery or ablation?: surgeon's perspective J Hepatobiliary Pancreat Sci 17 2010 422 424
31. S. Ueno, M. Sakoda, F. Kubo, K. Hiwatashi, T. Tateno, and Y. Baba Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria J Hepatobiliary Pancreat Surg 16 2009 359 366
32. M. Abu-Hilal, J.N. Primrose, A. Casaril, M.J. McPhail, N.W. Pearce, and N. Nicoli Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma J Gastrointest Surg 12 2008 1521 1526
33. A. Guglielmi, A. Ruzzenente, A. Valdegamberi, S. Pachera, T. Campagnaro, and M. D'Onofrio Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis J Gastrointest Surg 12 2008 192 198
34. A. Hiraoka, N. Horiike, Y. Yamashita, Y. Koizumi, K. Doi, and Y. Yamamoto Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications Hepatogastroenterology 55 2008 2171 2174
35. K. Hasegawa, M. Makuuchi, T. Takayama, N. Kokudo, S. Arii, and M. Okazaki Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey J Hepatol 49 2008 589 594
36. L. Lupo, P. Panzera, G. Giannelli, M. Memeo, A. Gentile, and V. Memeo Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford) 9 2007 429 434
37. M. Ogihara, L.L. Wong, and J. Machi Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: long-term outcomes HPB (Oxford) 7 2005 214 221
38. M. Montorsi, R. Santambrogio, P. Bianchi, M. Donadon, E. Moroni, and A. Spinelli Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis J Gastrointest Surg 9 2005 62 67
39. S.N. Hong, S.Y. Lee, M.S. Choi, J.H. Lee, K.C. Koh, and S.W. Paik Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function J Clin Gastroenterol 39 2005 247 252
40. M. Vivarelli, A. Guglielmi, A. Ruzzenente, A. Cucchetti, R. Bellusci, and C. Cordiano Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver Ann Surg 240 2004 102 107
41. G. Germani, M. Pleguezuelo, K. Gurusamy, T. Meyer, G. Isgrò, and A.K. Burroughs Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocellular carcinoma: a meta-analysis J Hepatol 52 2010 380 388
42. O. Seror, G. N'Kontchou, M. Ibraheem, Y. Ajavon, C. Barrucand, and N. Ganne Large (> or =5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes - initial experience in 26 patients Radiology 248 2008 288 296
43. G.J. Qian, N. Wang, Q. Shen, Y.H. Sheng, J.Q. Zhao, and M. Kuang Efficacy of microwave versus radiofrequency ablation for treatment of small hepatocellular carcinoma: experimental and clinical studies Eur Radiol 22 2012 1983 1990
44. A. Forner, J.M. Llovet, and J. Bruix Hepatocellular carcinoma Lancet 379 2012 1245 1255